Denosumab biosimilar by Sandoz Group for Humoral Hypercalcemia of Malignancy: Likelihood of Approval

Note that some links may require registration or subscription Two nurses and one medical resident at Newark Beth Israel Medical Center were slashed by a

House Over­sight Com­mit­tee Chair James Com­er (R-KY) is press­ing the FDA to share more in­for­ma­tion on its pres­ence in Chi­na amid grow­ing con­cerns on Capi­tol